If you have been reading about tetrapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Derived from the four-residue sequence |
| Molar mass | About 390.35 g/mol | Free peptide, counter-ion not included |
| Appearance | White to off-white powder | Lyophilised solid from aqueous solution |
| Water solubility | Freely soluble | Short, polar peptide chain |
| Common synonyms | AEDG; epithalone | Catalogues use the names interchangeably |
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Chemically, the molecule consists of four amino acid residues joined by three peptide bonds, with a free N-terminal amino group and a free C-terminal carboxyl group. Its molecular formula is C14H22N4O9, and its monoisotopic mass is approximately 390 daltons. The acidic glutamate and aspartate side chains give the peptide a net negative charge near neutral pH, a property that shapes its chromatographic behaviour and solubility profile. No disulfide bridges or other post-translational modifications are present, so the primary sequence alone defines the structure.
Most experimental work has been carried out in cell culture and animal models. Several reports describe changes in telomerase activity and proliferation in cultured cells, while rodent studies have examined lifespan, melatonin rhythm and reproductive endpoints. Human data remain limited, and much of the published clinical material consists of small trials with incomplete reporting of methods and controls. Whether the cell and animal findings translate into measurable effects in people is an open question, and the mechanistic basis of the reported telomerase changes is not fully established.
Both the new Law of Political Parties and the process of illegalization of Batasuna were strongly contested by the Basque nationalist parties and, as an alternative, the lehendakari Juan José Ibarretxe proposed a "pacification plan" based on the holding of a referendum regulating "the free association of Euskadi to the plurinational Spanish State". By the end of 2003, the tension between the central government and the "peripheral" nationalisms moved to Catalonia as a result of the formation of a left-wing "tri-party" government after the Catalan elections of November 2003 consisting of the Socialists' Party of Catalonia (PSC), Republican Left of Catalonia (ERC, a pro-independence party that had experienced a meteoric rise), and Initiative for Catalonia Greens (a party associated with United Left) and presided by the socialist Pasqual Maragall. The "Tinell Pact" of the PSC-PSOE, IC and ERC (in which the "tri-party" program was agreed, expressly excluding any agreement with the PP) was harshly criticized by the Aznar government and by the new PP leader Mariano Rajoy ─ who at the end of August 2003 had been proposed by Aznar to replace him as candidate in the following year's elections. By the end of January 2004, a scandal broke out that shook the "tri-party" government. In its 24th edition, the newspaper "ABC" published that the leader of ERC, Josep Lluís Carod Rovira, conseller en cap of the Generalitat, had met in Perpignan with the top leadership of ETA to negotiate an exclusive truce for Catalonia.
"Hem. Marker study, ADULTS over 16 years;Asc";Hem. Marker examination, ADULTS over 16 years, Ascites fluid;Hematology marker laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; count";Clinical Biochemistry Laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; numberk";, Clinical Biochemistry Laboratory "Leukocytes(mononuclear);Asc";"Asc-Leukocytes(mononuclear); count";Clinical Biochemistry Laboratory "Leukocytes(polynucleus);Asc";"Asc-Leukocytes(polynucleus); count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; numberk";Clinical Biochemistry Laboratory "Carbamide;Asc";"Asc-Carbamide; substancek";Clinical Biochemistry Laboratory "Calcium;Asc";"Asc-Calcium(II); substance c.";Clinical Biochemistry Laboratory "Phosphate;Asc";"Asc-Phosphate(P; inorganic); substance";Clinical Biochemistry Laboratory "Triglyceride;Asc";"Asc-Triglyceride; substance";Clinical Biochemistry Laboratory "Bilirubins;Asc";Asc-Bilirubins, substance;Clinical Biochemistry Laboratory "Albumin;Asc";"Asc-Albumin; bulk";Clinical Biochemistry Laboratory "Protein;Asc";"Asc-Protein; mass spec.";Clinical Biochemistry Laboratory "Amylase, pancreatic type;Asc";"Asc-Amylase, pancreatic type;cat.k.";Clinical Biochemistry Laboratory "Lactate dehydro ase;Asc";"Asc-Lactate dehydro ase;.";Clinical Biochemistry Laboratory "Cholesterol;Asc";"Asc-Cholesterol+ester; substance c.";Clinical Biochemistry Laboratory "Ascites group;Asc";"A Alternative list for Ascites fluid analyses: The following analyses (Normal Order Name; Designation in the laboratory; Laboratory) can be performed on the sample material Ascites fluid.
=== Brand names === Trimipramine is marketed throughout the world mainly under the brand name Surmontil. Other notable brand names of trimipramine have included Herphonal, Rhotrimine, Sapilent, Stangyl, and Tydamine.
Sources: en.wikipedia.org
== Menu and advertising == The first Taco Bell commercials premiered in 1968, featuring advertisements with Mel Blanc, Pat Harrington, and the then-host of Truth or Consequences, Bob Barker. In 1992, Johnny Cash starred in a television commercial for Taco Bell's value menu. In 1993, Taco Bell was used as product placement and plot device in the movie Demolition Man updating their currently used logo. From August 1997 to July 2000, Gidget the Chihuahua was the brand's advertising mascot, a campaign developed by TBWA. Voiced by Carlos Alazraqui, slogans included “¡Yo quiero Taco Bell!” (I want Taco Bell!), “Drop the Chalupa,” and “¡Viva Gorditas!” All became catchphrases in popular culture. In 2000, Taco Bell: Tasty Temple Challenge was released for DOS by Taco Bell as the publisher and developed by BrandGames as a kid-friendly first-person 3D action shooter with gameplay similar to that of Doom and Wolfenstein 3D in terms of combat and exploration, serving as an advertisement for the brand. The player controls Baja Bill, who explores a temple of a lost jungle civilization, battling snakes and scorpions with Taco Bell's hot and wild sauce. Food from the brand also appears in game and is used to replenish the protagonist's health.
The presence of bulky ligands can also increase the rate of elimination. Ligands such as phosphines with large bite angles cause steric repulsion between L and R1 and R2, resulting in the angle between L and the R groups to increase and the angle between R1 and R2 to hence decrease, allowing for quicker reductive elimination.
The AlphaFold Protein Structure Database (AlphaFold DB) is a collaborative project with Google DeepMind to make predicted protein structures from the AlphaFold AI system freely available to the scientific community. The first release of the database was in 2021; as of 2024, AlphaFold DB provides access to over 214 million protein structures. National Center for Biotechnology Information (NCBI), United States National Library of Medicine National Institute of Genetics (DNA Data Bank of Japan) Swiss Institute of Bioinformatics (SIB: Expasy) Australia Bioinformatics Resource BIG Data Center (National Genomics Data Center), Beijing Institute of Genomics, Chinese Academy of Sciences Alternative splicing and transcript diversity database BioJS - open-source project for bioinformatics data on the web BioSamples European Molecular Biology Organization European Nucleotide Archive
Sources: en.wikipedia.org
It is a synthetic tetrapeptide built from alanine, glutamate, aspartate and glycine. The four residues are joined by standard peptide bonds, giving a linear chain rather than a branched structure.
The name derives from epithalamin, a pineal gland extract studied in the former Soviet Union. Researchers proposed that short fragments of that extract carried the biological activity of interest.
No major regulatory agency has approved it as a medicine. It is handled as a research chemical, and products sold under this name are not standardised drugs with defined clinical labelling.
It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.